143 related articles for article (PubMed ID: 2896149)
1. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.
Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M
Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149
[TBL] [Abstract][Full Text] [Related]
2. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Moattari AR; Cho K; Vinik AI
Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
[TBL] [Abstract][Full Text] [Related]
4. [Metastatic glucagonoma. Complete remission by dacarbazine (5 years' recession)].
Jeanmougin M; Civatte J; Bonvalet D; Passa P; Verola O; Zylberait D
Ann Dermatol Venereol; 1988; 115(8):833-8. PubMed ID: 2849362
[No Abstract] [Full Text] [Related]
5. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
[No Abstract] [Full Text] [Related]
6. [Glucagonoma syndrome with normal blood glucagon ].
Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
[No Abstract] [Full Text] [Related]
7. [Iatrogenic glucagonoma syndrome?].
Benhamou PY; Reymond JL; Boizel R; Béani JC; Amblard P
Ann Dermatol Venereol; 1988; 115(6-7):717-9. PubMed ID: 2849361
[No Abstract] [Full Text] [Related]
8. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
Elsborg L; Glenthøj A
Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
[TBL] [Abstract][Full Text] [Related]
9. Glucagonoma syndrome.
Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
[TBL] [Abstract][Full Text] [Related]
10. [The glucagonoma syndrome--a not-so-well-known cutaneous paraneoplastic condition. Case report].
Galle K; Schweiss D
Hautarzt; 1984 Apr; 35(4):204-9. PubMed ID: 6327570
[TBL] [Abstract][Full Text] [Related]
11. The glucagonoma syndrome.
Bloom SR; Sonksen PH
J R Soc Med; 1990 Jan; 83(1):60. PubMed ID: 1968103
[No Abstract] [Full Text] [Related]
12. [Mixed endocrine tumor of the pancreas (vipoma, glucagonoma). Treatment by somatostatin followed by one of its long-acting analogs].
Kaloustian E; Guillauseau PJ; Chayvialle JA; Veyssier P; Lallement PY; Latrive JP; Zylberait D; Lubetzki J
Presse Med; 1987 Dec; 16(44):2217-20. PubMed ID: 2893369
[TBL] [Abstract][Full Text] [Related]
13. The glucagonoma syndrome.
Sonksen PH; Bloom SR
J R Soc Med; 1990 Feb; 83(2):127. PubMed ID: 1969482
[No Abstract] [Full Text] [Related]
14. [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
Bouin M; Aoust LD
Gastroenterol Clin Biol; 2002 Oct; 26(10):926-9. PubMed ID: 12434103
[TBL] [Abstract][Full Text] [Related]
15. Disappearance of glucagonoma rash after surgical resection, but not during dietary normalization of serum amino acids.
Abraira C; DeBartolo M; Katzen R; Lawrence AM
Am J Clin Nutr; 1984 Mar; 39(3):351-5. PubMed ID: 6320631
[TBL] [Abstract][Full Text] [Related]
16. Response of glucagonoma syndrome to lomustine.
Khandekar JD; Sriratana P
Cancer Treat Rep; 1986 Mar; 70(3):433-4. PubMed ID: 3006914
[No Abstract] [Full Text] [Related]
17. [The glucagonomas (author's transl)].
Luyckx AS; Lefebvre PJ
Diabete Metab; 1981 Dec; 7(4):289-300. PubMed ID: 6120860
[No Abstract] [Full Text] [Related]
18. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R
Digestion; 1989; 42(2):116-20. PubMed ID: 2548911
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural studies of necrolytic migratory erythema.
Ohyama K; Kitoh M; Arao T
Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
[TBL] [Abstract][Full Text] [Related]
20. Amino acid, glucose, and lipid kinetics after palliative resection in a patient with glucagonoma syndrome.
Bernstein M; Jahoor F; Townsend CM; Klein S
Metabolism; 2001 Jun; 50(6):720-2. PubMed ID: 11398151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
